Saturday, August 1, 2020

Student creates a robotic guide dog for visually impaired

This article is by

Share this article

Article Contributor(s)

Charvi Trivedi

Article Title

Student creates a robotic guide dog for visually impaired

Publisher

Global Views 360

Publication Date

August 1, 2020

URL

The prototype of handheld robotic guide dog

The prototype of handheld robotic guide dog | Source: Anthony Camu via Loughborough University

Anthony Camu, a final year Industrial Design and Technology student at Loughborough University is making headlines with his latest creation of a handheld robotic guide dog. This will be a great help to those people with visual impairment who might find it difficult to accommodate an actual guide dog in their homes.

The robot is named after the Titan goddess of light, ‘Theia’ and is shaped like a virtual gaming controller, which enthused Anthony to create this masterpiece in the first place. Theia listens to the user’s voice to lead them to their desired locations.

If the user has to go to some address (for eg. House number 4, 56th Street, Greenville Residency), they have to say ‘Hey Theia take me to House number 4, 56th Street, Greenville Residency*’. It will then process the actual data available online, like traffic density, and program the most secure route for the user to follow, quite similar to how GPS or satellite navigation works in our cars.

All the information is then communicated to the user via a machine built inside it, called a control moment gyroscope which uses the mechanism of ‘forced feedback’. These are used in spacecraft and their main function is to help in orientation purposes of the spacecraft, or in controlling the ‘spacecraft attitude’ using electric power.

This tiny built-in gyroscope physically moves the user’s hand in the direction they are supposed to go, thus giving them a feeling of being led by an actual guide dog. “The main intention was never to replace guide dogs, but instead to provide an alternative means of giving enhanced mobility options to visually impaired people” says Anthony Camu.

According to Mr. Camu, Theia will also be helpful in confronting challenging interactions like elevators or shops. While crossing a busy street, it will tend to ‘push back’ the users, cautioning them to be more sentient about their current surroundings. Moreover, Theia is quite pocket-friendly, costing about one-tenth the price of a real guide dog.

This tool will also contribute in imparting a sense of belonging and reduce the constant mental hassle and anxiety faced by the visually impaired population of the world. Since they are unable to assess their surroundings, it limits their outdoor movement. This will help them move in the outdoors more often and reduce stress while navigating the traffic on the road.

Anthony has created and experimented with many prototypes of Theia and some work is still needed to correct a few issues before the final launch his product in the market

However, he concluded that Theia has a promising future and it requires just a little more testing and research.“I know this is a grand vision, but I hope people can see the positive effects Theia could have on the blind community” he states.

*This address is fictional. Any similarity is purely coincidental.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 4:48 PM

The Coronavirus Disease

Severe acute respiratory syndrome-Coronavirus 2 (SARS-CoV-2) is a novel virus from the family of coronaviruses which causes COVID-19 i.e. Coronavirus Disease-2019. It is the successor of the SARS-CoV-1 which caused the SARS outbreak in the year 2003-2004. This is a positive-sense single-stranded RNA virus which has rapid mutation properties.

The etymology of the name suggests that 'Corona' comes from the Latin word corōna meaning crown, garland, or a wreath. When seen under an Electron Microscope, the virion which has a diameter of 50-200 nanometres looks like the solar corona hence named Coronavirus.

When the virus enters the body; it attaches itself to the binding site or the ACE 2 receptors of healthy lung cells through its spike protein. Then it enters the cell via this attachment and causes apoptosis or cell death. The virus also affects organs other than lungs such as the brain, heart and kidneys. The multiple impact points make it problematic for the researchers to create a vaccine in addition to its rapid mutation properties.

The disease might have a zoonotic origin i.e. the transmission occurs from animals to humans. On comparing the genomic sequences the Human Coronavirus strain is found to be 96% identical to Bat Coronavirus samples and 92% similar to the Pangolins samples. Human transmission of the disease takes place via air droplets when the infected person is coughing, sneezing or talking.

The first cases of this respiratory illness were reported to the World Health Organization (WHO) from Wuhan City, Hubei Province, China, on 31 December 2019. It is the first severe outbreak since the 2009 H1N1 Influenza Pandemic. Initially, it was supposed that the site of origination is Huanan Seafood Wholesale Market but, in May 2020 the negative samples tested, by  Chinese Center for Disease Control and Prevention, from the livestock market suggested that it was the site of the super spreading of the virus.

SARS-CoV-2 is known to have an average reproduction number of 2.2-2.6 which means that, on an average, one infected person can spread the infection to 2-3 people. Although if measures like social distancing are put into use, to reduce the exposure of the infected population, it leads to a significant reduction in transmission rates. The infection fatality rate (IFR) of COVID-19 in various studies till 16th June 2020 was projected to range 0.60% to 1% of infected people . However few studies suggested the IFR as high as 3.6%.

The testing of an individual takes place through a method known as real-time Reverse transcription Polymerization Chain reaction (rRT-PCR). The process of obtaining strains and testing the patients usually involves nasal swabs or sputum swabs; the results come in within a span of a few hours to a couple of days.

Currently, there are no known vaccines available for the virus or any specific antiviral treatments, but there are numerous vaccines in works all over the world to tackle COVID-19. Experts believe that the minimum time required to test a vaccine is 12 to 18 months.

Trials are also going on for the repurposed drugs or the drugs which are useful for treating other diseases and might be capable against COVID-19: Some of these drugs are Hydroxychloroquine, chloroquine, Remdesivir, Dexamethasone, Lopinavir-ritonavir, and Convalescent plasma.

The only current solutions for tackling the pandemic are social distancing, hand wash, hygiene and face masks.

Read More